Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?

Goodwin Pamela J

J Clin Oncol. 2003 Dec 15;21(24):4474-5. doi: 10.1200/JCO.2003.07.966. Epub 2003 Nov 10.

Abstract

摘要

相似文献

J Clin Oncol. 2003 Dec 15;21(24):4474-5. doi: 10.1200/JCO.2003.07.966. Epub 2003 Nov 10.

J Clin Oncol. 2007 Jan 20;25(3):263-70. doi: 10.1200/JCO.2005.04.5393. Epub 2006 Dec 11.

J Clin Oncol. 2003 Dec 15;21(24):4510-6. doi: 10.1200/JCO.2003.11.064. Epub 2003 Nov 10.

Eur J Cancer. 2004 Nov;40(16):2403-10. doi: 10.1016/j.ejca.2004.07.013.

Eur J Cancer. 2006 Aug;42(12):1780-8. doi: 10.1016/j.ejca.2006.04.006. Epub 2006 Jun 12.

J Clin Oncol. 2003 Jun 15;21(12):2444-5; author reply 2446-7. doi: 10.1200/JCO.2003.99.016.

Expert Rev Anticancer Ther. 2005 Aug;5(4):591-604. doi: 10.1586/14737140.5.4.591.

Breast Cancer Res Treat. 2009 Oct;117(3):561-7. doi: 10.1007/s10549-009-0313-5. Epub 2009 Jan 20.

J Natl Cancer Inst. 2007 Apr 4;99(7):506-15. doi: 10.1093/jnci/djk108.

J Natl Cancer Inst. 2003 Dec 17;95(24):1811-2. doi: 10.1093/jnci/djg133.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。